RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 16, 2017

Total Value: $706M (100.0% shares, 0.0% debt)

Holdings (27)

WVE WAVE LIFE SCIENCES LTD 26.3%
Value $185M Shares 7,088,651 Share Price $26.15 * Est. Cost/Share $15.68 Unrealized @ Report Date +107.4%
ASND ASCENDIS PHARMA A S 15.5%
Value $109M Shares 5,409,990 Share Price $20.24 Est. Cost/Share $17.65 Unrealized @ Report Date —
— AVEXIS INC 12.8%
Value $90.25M Shares 1,890,796 Share Price $47.73 Est. Cost/Share $31.86 Unrealized @ Report Date —
— ACHILLION PHARMACEUTICALS INC 8.0%
Value $56.3M Shares 13,633,220 Share Price $4.13 Est. Cost/Share $6.18 Unrealized @ Report Date —
— AQUINOX PHARMACEUTICALS INC 5.1%
Value $36.19M Shares 2,191,977 Share Price $16.51 Est. Cost/Share $13.67 Unrealized @ Report Date —
— ZOGENIX INC 4.2%
Value $29.78M Shares 2,451,237 Share Price $12.15 Est. Cost/Share $13.32 Unrealized @ Report Date —
ARDX ARDELYX INC 3.9%
Value $27.48M Shares 1,935,305 Share Price $14.20 Est. Cost/Share $10.51 Unrealized @ Report Date +35.0%
— RA PHARMACEUTICALS INC 2.9%
Value $20.53M Shares 1,351,808 Share Price $15.19 Est. Cost/Share $15.19 Unrealized @ Report Date —
— FOAMIX PHARMACEUTICALS LTD 2.9%
Value $20.2M Shares 1,820,138 Share Price $11.10 Est. Cost/Share $9.26 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 2.7%
Value $18.93M Shares 2,989,795 Share Price $6.33 * Est. Cost/Share $9.58 Unrealized @ Report Date -45.7%
— MYOVANT SCIENCES LTD 2.6%
Value $18.66M Shares 1,500,000 Share Price $12.44 Est. Cost/Share $12.44 Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 2.1%
Value $14.63M Shares 692,563 Share Price $21.13 * Est. Cost/Share $13.67 Unrealized @ Report Date +63.1%
— AIMMUNE THERAPEUTICS INC 2.0%
Value $13.86M Shares 677,663 Share Price $20.45 Est. Cost/Share $20.75 Unrealized @ Report Date —
— AUDENTES THERAPEUTICS INC 1.4%
Value $9.727M Shares 532,426 Share Price $18.27 Est. Cost/Share $17.81 Unrealized @ Report Date —
ONC BEIGENE LTD 1.0%
Value $7.286M Shares 240,000 Share Price $30.36 Est. Cost/Share $29.62 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 1.0%
Value $6.994M Shares 2,428,571 Share Price $2.88 Est. Cost/Share $28.25 Unrealized @ Report Date —
— ABEONA THERAPEUTICS INC 0.8%
Value $5.543M Shares 1,142,857 Share Price $4.85 Est. Cost/Share $4.85 Unrealized @ Report Date —
— STRONGBRIDGE BIOPHARMA PLC 0.8%
Value $5.47M Shares 2,279,099 Share Price $2.40 Est. Cost/Share $7.60 Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 0.7%
Value $4.67M Shares 1,004,314 Share Price $4.65 * Est. Cost/Share $10.06 Unrealized @ Report Date -41.7%
— TENAX THERAPEUTICS INC 0.7%
Value $4.66M Shares 2,389,700 Share Price $1.95 Est. Cost/Share $3.92 Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 0.6%
Value $4.179M Shares 591,070 Share Price $7.07 * Est. Cost/Share $7.37 Unrealized @ Report Date 0.0%
— EIGER BIOPHARMACEUTICALS INC 0.6%
Value $4.126M Shares 354,200 Share Price $11.65 Est. Cost/Share $16.17 Unrealized @ Report Date —
— DIMENSION THERAPEUTICS INC 0.6%
Value $4.038M Shares 928,199 Share Price $4.35 Est. Cost/Share $10.25 Unrealized @ Report Date —
— IDERA PHARMACEUTICALS INC 0.5%
Value $3.375M Shares 2,250,000 Share Price $1.50 Est. Cost/Share $1.50 Unrealized @ Report Date —
— MEDICINES CO 0.4%
Value $2.712M Shares 79,899 Share Price $33.94 Est. Cost/Share $33.94 Unrealized @ Report Date —
— AKARI THERAPEUTICS PLC 0.1%
Value $714K Shares 101,439 Share Price $7.04 Est. Cost/Share $24.00 Unrealized @ Report Date —
— ARCA BIOPHARMA INC 0.1%
Value $662K Shares 232,245 Share Price $2.85 Est. Cost/Share $4.96 Unrealized @ Report Date —